Subtle Changes in Peptide Conformation Profoundly Affect Recognition of the Non-Classical MHC Class I Molecule HLA-E by the CD94-NKG2 Natural Killer Cell Receptors

Journal of Molecular Biology

Volumn 377, Issue 5, 2008, Pages 1297-1303

  Hoare, Hilary L ^a   Sullivan, Lucy C ^b   Clements, Craig S ^a   Ely, Lauren K ^a   Beddoe, Travis ^a   Henderson, Kate N ^a   Lin, Jie ^b   Reid, Hugh H ^a   Brooks, Andrew G ^b   Rossjohn, Jamie ^a  

^a Department of Physiology School of Biomedical Sciences   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

CD94 NKG2A; Human Leukocyte Antigen E (HLA E); innate immunity; NK receptors

Indexed keywords

CD94 ANTIGEN; HLA E ANTIGEN; NATURAL KILLER CELL RECEPTOR NKG2A;

ARTICLE; CIRCULAR DICHROISM; CRYSTAL STRUCTURE; HUMAN; HYDROGEN BOND; INNATE IMMUNITY; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; THERMOSTABILITY; ULTRAVIOLET SPECTROSCOPY;

EID: 40849101548     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2008.01.098     Document Type: Article

References (30)

1. Lodoen M.B., and Lanier L.L. Viral modulation of NK cell immunity. Nat. Rev. Microbiol. 3 (2005) 59-69
2. Lanier L.L. NK cell receptors. Annu. Rev. Immunol. 16 (1998) 359-393
3. Brooks A.G., Borrego F., Posch P.E., Patamawenu A., Scorzelli C.J., Ulbrecht M., et al. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells. J. Immunol. 162 (1999) 305-313
4. Lazetic S., Chang C., Houchins J.P., Lanier L.L., and Phillips J.H. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J. Immunol. 157 (1996) 4741-4745
5. Natarajan K., Dimasi N., Wang J., Mariuzza R.A., and Margulies D.H. Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. Annu. Rev. Immunol. 20 (2002) 853-885
6. + T cell clone upon the aggregation of an activatory CD94/kp39 heterodimer. J. Immunol. 162 (1999) 3996-4002
7. Brooks A.G., Posch P.E., Scorzelli C.J., Borrego F., and Coligan J.E. NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor. J. Exp. Med. 185 (1997) 795-800
8. Borrego F., Ulbrecht M., Weiss E.H., Coligan J.E., and Brooks A.G. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. Med. 187 (1998) 813-818
9. Braud V.M., Allan D.S., O'Callaghan C.A., Soderstrom K., D'Andrea A., Ogg G.S., et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391 (1998) 795-799
10. Shawar S.M., Vyas J.M., Rodgers J.R., and Rich R.R. Antigen presentation by major histocompatibility complex class I-B molecules. Annu. Rev. Immunol. 12 (1994) 839-880
11. Braud V., Jones E.Y., and McMichael A. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur. J. Immunol. 27 (1997) 1164-1169
12. Lee N., Llano M., Carretero M., Ishitani A., Navarro F., Lopez-Botet M., and Geraghty D.E. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl Acad. Sci. USA 95 (1998) 5199-5204
13. O'Callaghan C.A., and Bell J.I. Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G. Immunol. Rev. 163 (1998) 129-138
14. O'Callaghan C.A., Tormo J., Willcox B.E., Braud V.M., Jakobsen B.K., Stuart D.I., et al. Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E. Mol. Cell 1 (1998) 531-541
15. Llano M., Lee N., Navarro F., Garcia P., Albar J.P., Geraghty D.E., and Lopez-Botet M. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Eur. J. Immunol. 28 (1998) 2854-2863
16. Bland F.A., Lemberg M.K., McMichael A.J., Martoglio B., and Braud V.M. Requirement of the proteasome for the trimming of signal peptide-derived epitopes presented by the nonclassical major histocompatibility complex class I molecule HLA-E. J. Biol. Chem. 278 (2003) 33747-33752
17. Kaiser B.K., Barahmand-Pour F., Paulsene W., Medley S., Geraghty D.E., and Strong R.K. Interactions between NKG2x immunoreceptors and HLA-E ligands display overlapping affinities and thermodynamics. J. Immunol. 174 (2005) 2878-2884
18. Vales-Gomez M., Reyburn H.T., Erskine R.A., Lopez-Botet M., and Strominger J.L. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. EMBO J. 18 (1999) 4250-4260
19. Strong R.K., Holmes M.A., Li P., Braun L., Lee N., and Geraghty D.E. HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities. J. Biol. Chem. 278 (2003) 5082-5090
20. Hoare H.L., Sullivan L.C., Pietra G., Clements C.S., Lee E.J., Ely L.K., et al. Structural basis for a major histocompatibility complex class Ib-restricted T cell response. Nat. Immunol. 7 (2006) 256-264
21. Sullivan L.C., Hoare H.L., McCluskey J., Rossjohn J., and Brooks A.G. A structural perspective on MHC class Ib molecules in adaptive immunity. Trends Immunol. 27 (2006) 413-420
22. Clements C.S., Dunstone M.A., Macdonald W.A., McCluskey J., and Rossjohn J. Specificity on a knife-edge: the alphabeta T cell receptor. Curr. Opin. Struct. Biol. 16 (2006) 787-795
23. Rudolph M.G., Stanfield R.L., and Wilson I.A. How TCRs bind MHCs, peptides, and coreceptors. Annu. Rev. Immunol. 24 (2006) 419-466
24. Sullivan L.C., Clements C.S., Beddoe T., Johnson D., Hoare H.L., Lin J., et al. The heterodimeric assembly of the CD94-NKG2 receptor family and implications for human leukocyte antigen-E recognition. Immunity 27 (2007) 900-911
25. Reid S.W., McAdam S., Smith K.J., Klenerman P., O'Callaghan C.A., Harlos K., et al. Antagonist HIV-1 Gag peptides induce structural changes in HLA B8. J. Exp. Med. 184 (1996) 2279-2286
26. Kjer-Nielsen L., Clements C.S., Brooks A.G., Purcell A.W., Fontes M.R., McCluskey J., and Rossjohn J. The structure of HLA-B8 complexed to an immunodominant viral determinant: peptide-induced conformational changes and a mode of MHC class I dimerization. J. Immunol. 169 (2002) 5153-5160
27. Macdonald W.A., Purcell A.W., Mifsud N.A., Ely L.K., Williams D.S., Chang L., et al. A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition. J. Exp. Med. 198 (2003) 679-691
28. Boyington J.C., Raiz A.N., Brooks A.G., Patamawenu A., and Sun P.D. Reconstitution of bacterial expressed human CD94: the importance of the stem region for dimer formation. Protein Expression Purif. 18 (2000) 235-241
29. Garboczi D.N., Hung D.T., and Wiley D.C. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl. Acad. Sci. USA 89 (1992) 3429-3433
30. Chang L., Kjer-Nielsen L., Flynn S., Brooks A.G., Mannering S.I., Honeyman M.C., et al. Novel strategy for identification of candidate cytotoxic T-cell epitopes from human preproinsulin. Tissue Antigens 62 (2003) 408-417